Empagliflozin, a selective SGLT2 inhibitor, ameliorated hyperglycaemia and insulin resistance, while preserving the integrity of pancreas and kidney in CRDH rats

DIABETOLOGIA(2014)

引用 0|浏览5
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要